Banner Publications MH200828 N141

Publications

Results found: 6067

Showing results: 5851 - 5900

Biochimica et biophysica acta

Characterization of the promoter region of the human MDR3 P-glycoprotein gene.

14-03-1995
International immunology

Assembly and intracellular transport of the human B cell antigen receptor complex.

01-03-1995
Cancer treatment reviews

High-dose chemotherapy regimens for solid tumors.

01-03-1995
Immunogenetics

A susceptibility gene for alveolar lung tumors in the mouse maps between Hsp70.3 and G7 within the H2 complex.

01-01-1995
Cancer chemotherapy and pharmacology

Isolation, purification, and biological activity of mono- and dihydroxylated paclitaxel metabolites from human feces.

01-01-1995
Journal of cancer research and clinical oncology

The use of the Calvert formula to determine the optimal carboplatin dosage.

01-01-1995
Experimental cell research

The cytoplasmic domain of alpha 6A integrin subunit is an in vitro substrate for protein kinase C.

01-01-1995
Biochimica et biophysica acta

Growth factor-like effects of lysophosphatidic acid, a novel lipid mediator.

30-12-1994
Prostaglandins

Radiation reduces cyclooxygenase activity in cultured human endothelial cells at low doses.

01-12-1994
The Journal of cell biology

The mucin epiglycanin on TA3/Ha carcinoma cells prevents alpha 6 beta 4-mediated adhesion to laminin and kalinin and E-cadherin-mediated cell-cell interaction.

01-12-1994
Genes & development

E2F-4, a new member of the E2F gene family, has oncogenic activity and associates with p107 in vivo.

15-11-1994
FEBS letters

The human MDR3 P-glycoprotein promotes translocation of phosphatidylcholine through the plasma membrane of fibroblasts from transgenic mice.

14-11-1994
Laboratory investigation; a journal of technical methods and pathology

Tissue distribution of the human MDR3 P-glycoprotein.

01-11-1994
International journal of radiation oncology, biology, physics

Evidence for a renovascular component in hypertensive patients with late radiation nephropathy.

15-10-1994
Lancet (London, England)

Oral contraceptives and risk of breast cancer in women aged 20-54 years. Netherlands Oral Contraceptives and Breast Cancer Study Group.

24-09-1994
The EMBO journal

Developmental rescue of an embryonic-lethal mutation in the retinoblastoma gene in chimeric mice.

15-09-1994
The EMBO journal

Interaction of c-Myc with the pRb-related protein p107 results in inhibition of c-Myc-mediated transactivation.

01-09-1994
The Journal of biological chemistry

B cell antigen receptor stimulation induces formation of a Shc-Grb2 complex containing multiple tyrosine-phosphorylated proteins.

12-08-1994
The Journal of cell biology

Major histocompatibility complex class II molecules induce the formation of endocytic MIIC-like structures.

01-08-1994
Clinical otolaryngology and allied sciences

Communication, functional disorders and lifestyle changes after total laryngectomy.

01-08-1994
The Journal of cell biology

Inhibition of lysophosphatidate- and thrombin-induced neurite retraction and neuronal cell rounding by ADP ribosylation of the small GTP-binding protein Rho.

01-08-1994
British journal of cancer

Melphalan tissue concentrations in patients treated with regional isolated perfusion for melanoma of the lower limb.

01-07-1994
Pharmacy world & science : PWS

Bioanalysis and pharmacokinetics of (investigational) vinca alkaloids.

10-06-1994
The EMBO journal

Reconstitution of a surface transferrin binding complex in insect form Trypanosoma brucei.

01-06-1994
Cell

Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs.

20-05-1994
Cell

Identification of an invasion-inducing gene, Tiam-1, that encodes a protein with homology to GDP-GTP exchangers for Rho-like proteins.

20-05-1994
Oncogene

Kras-2 alleles, mutations, and lung tumor susceptibility in the mouse--an evaluation.

01-05-1994
Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Leukemia risk following Hodgkin's disease: relation to cumulative dose of alkylating agents, treatment with teniposide combinations, number of episodes of chemotherapy, and bone marrow damage.

01-05-1994
Virology

Mutagenesis and characterization of a 41-kilobase-pair region of the pseudorabies virus genome: transcription map, search for virulence genes, and comparison with homologs of herpes simplex virus type 1.

01-05-1994
European journal of immunology

Targeting major histocompatibility complex class II molecules to the cell surface by invariant chain allows antigen presentation upon recycling.

01-04-1994
Experimental cell research

The alpha 6 beta 4 integrin is a receptor for both laminin and kalinin.

01-04-1994
Genes & development

Posterior transformation, neurological abnormalities, and severe hematopoietic defects in mice with a targeted deletion of the bmi-1 proto-oncogene.

01-04-1994
European journal of immunology

CD3 components at the surface of pro-T cells can mediate pre-T cell development in vivo.

01-04-1994
Lancet (London, England)

Risk of endometrial cancer after tamoxifen treatment of breast cancer.

19-02-1994
The Journal of biological chemistry

cAMP abrogates the p21ras-mitogen-activated protein kinase pathway in fibroblasts.

04-02-1994
Annals of oncology : official journal of the European Society for Medical Oncology

Toxicity grading systems. A comparison between the WHO scoring system and the Common Toxicity Criteria when used for nausea and vomiting.

01-02-1994
Radiation research

Ionizing radiation enhances platelet adhesion to the extracellular matrix of human endothelial cells by an increase in the release of von Willebrand factor.

01-02-1994
Annals of oncology : official journal of the European Society for Medical Oncology

Intraperitoneal-administered carboplatin in patients with ovarian cancer; influence of a dwell-time on toxicity and response.

01-02-1994
Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Second cancer risk following Hodgkin's disease: a 20-year follow-up study.

01-02-1994
Annals of oncology : official journal of the European Society for Medical Oncology

The quality of life of long-term survivors of Hodgkin's disease.

01-02-1994
Journal of cell science

Expression of the integrin alpha 6 beta 4 in peripheral nerves: localization in Schwann and perineural cells and different variants of the beta 4 subunit.

01-02-1994
Molecular biology of the cell

Distinct and overlapping ligand specificities of the alpha 3A beta 1 and alpha 6A beta 1 integrins: recognition of laminin isoforms.

01-02-1994
Journal of chromatography

Fully automated high-performance liquid chromatographic method for the determination of carzelesin (U-80,244) and metabolites (U-76,073 and U-76,074) in human plasma.

14-01-1994
Cancer chemotherapy and pharmacology

Pharmaceutical development of a parenteral lyophilized formulation of the novel indoloquinone antitumor agent EO9.

01-01-1994
Cold Spring Harbor symposia on quantitative biology

Mouse model systems to study multistep tumorigenesis.

01-01-1994
Cancer chemotherapy and pharmacology

The pharmacokinetics of reduced folates after intraperitoneal and intravenous administration of racemic [6S,R]-folinic acid.

01-01-1994
Annals of oncology : official journal of the European Society for Medical Oncology

Etoposide, leucovorin, 5-fluorouracil (ELF) combination chemotherapy for advanced gastric cancer: experience with two treatment schedules incorporating intravenous or oral etoposide.

01-01-1994
Cancer chemotherapy and pharmacology

Lithium pharmacokinetics during cisplatin-based chemotherapy: a case report.

01-01-1994
Investigational new drugs

Pharmaceutical development of a parenteral formulation of the novel anti-tumor agent carzelesin (U-80,244).

01-01-1994
Cancer chemotherapy and pharmacology

Plasma pharmacokinetics, tissue disposition, excretion and metabolism of vinleucinol in mice as determined by high-performance liquid chromatography.

01-01-1994

This site uses cookies

This website uses cookies to ensure you get the best experience on our website.